Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 12, 2025 08:22 ET | Source: Magstim EGI

FDA Clears Magstim Magnetic Stimulation for Chronic Pain Treatment

Millions living with chronic pain now have a new, FDA-cleared, non-invasive, and drug-free treatment option with Magstim Magnetic Stimulation.
November 10, 2025 04:00 ET | Source: Alvotech

Alvotech vinnur sigur í mikilvægu dómsmáli um framleiðslu og markaðssetningu AVT06 hliðstæðunnar við Eylea (aflibercept)

Alvotech (NASDAQ: ALVO, ALVO SDB) tilkynnti í dag að dómstóll í Bretlandi hafi hafnað lögbannskröfu Regeneron Pharmaceuticals og Bayer sem beindist að Alvotech og þjónustuaðila félagsins í Bretlandi....
November 10, 2025 04:00 ET | Source: Alvotech

UK High Court Rules in Favor of Alvotech Paving Way for Manufacture and Market Entry of AVT06, biosimilar to Eylea® (aflibercept)

REYKJAVIK, ICELAND (November 10, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced...
October 30, 2025 08:45 ET | Source: Cycurion

Cycurion Launches Strategic Cybersecurity Webinar Series to Fortify Public Sector Defenses

MCLEAN, Va., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. ("Cycurion" or the "Company") (NASDAQ: CYCU), a publicly traded leader in technology and staffing solutions for the public sector, today...
October 28, 2025 10:52 ET | Source: Cycurion

Cycurion Shareholder Letter Explains Path to Expanded Margins and Recurring Revenue for 2026

MCLEAN, Va., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ: CYCU) (“Cycurion” or the “Company”), a leading cybersecurity solutions provider, today issued the following press release to...
October 16, 2025 08:45 ET | Source: Cycurion

Cycurion Announces Five New Contracts Totaling $1 Million, Expanding into Commercial Sectors

MCLEAN, Va., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Cycurion (NASDAQ: CYCU), a leading provider of cybersecurity solutions, today announced the successful closure of five new contracts in September,...
October 06, 2025 15:19 ET | Source: Robbins LLP

MOH Stockholders: Robbins LLP Reminds Molina Healthcare, Inc. Stockholders of the Class Action Lawsuit

Robbins LLP is Investigating Allegations that Molina Healthcare, Inc. (MOH) Mislead Investors Regarding its Business Prospects.
September 22, 2025 15:41 ET | Source: Robbins LLP

JSPR Stockholder Alert: Robbins LLP Reminds Investors of the Securities Fraud Class Action Against Jasper Therapeutics, Inc.

Robbins LLP is Investigating Allegations that Jasper Therapeutics, Inc. (JSPR) Misled Investors Regarding the Commercial Prospects of its Lead Product
September 22, 2025 04:30 ET | Source: Alvotech

Lyfjastofnun Evrópu mælir með leyfi til markaðssetningar á Gobivaz, fyrirhugaðri hliðstæðu Alvotech við líftæknilyfið Simponi (golimumab)

Mannalyfjanefnd (CHMP) Lyfjastofnunar Evrópu (EMA) hefur mælt með því að heimila markaðssetningu AVT05, sem er fyrirhuguð hliðstæða líftæknilyfsins Simponi (golimumab), sem þróuð var af Alvotech....
September 22, 2025 04:30 ET | Source: Alvotech

European Medicines Agency Recommends Marketing Approval of Gobivaz®, Alvotech’s Proposed Biosimilar to Simponi® (golimumab) with Advanz Pharma as Commercialization Partner

REYKJAVIK, ICELAND and LONDON, UK (September 22, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients...